Basic information Safety Supplier Related

3-CHLORO-6,7-DIHYDRO[1,4]DIOXINO[2,3-C]PYRIDAZINE

Basic information Safety Supplier Related

3-CHLORO-6,7-DIHYDRO[1,4]DIOXINO[2,3-C]PYRIDAZINE Basic information

Product Name:
3-CHLORO-6,7-DIHYDRO[1,4]DIOXINO[2,3-C]PYRIDAZINE
Synonyms:
  • 3-CHLORO-6,7-DIHYDRO[1,4]DIOXINO[2,3-C]PYRIDAZINE
  • [1,4]Dioxino[2,3-c]pyridazine, 3-chloro-6,7-dihydro-
  • 3-chloro-6H,7H-[1,4]dioxino[2,3-c]pyridazine
CAS:
943026-40-2
MF:
C6H5ClN2O2
MW:
172.57
Mol File:
943026-40-2.mol
More
Less

3-CHLORO-6,7-DIHYDRO[1,4]DIOXINO[2,3-C]PYRIDAZINE Chemical Properties

Boiling point:
351.2±42.0 °C(Predicted)
Density 
1.478±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
1.52±0.20(Predicted)
Appearance
White to yellow Solid
More
Less

3-CHLORO-6,7-DIHYDRO[1,4]DIOXINO[2,3-C]PYRIDAZINE Usage And Synthesis

Synthesis

17284-80-9

943026-40-2

General procedure for the synthesis of 3-chloro-6,7-dihydro[1,4]dioxohexa[2,3-c]pyridazine from the compound (CAS:17284-80-9): (c) 2-[(3,6-dichloro-4-pyridazinyl)oxy]ethanol (15.46 g; 0.0703 mol) containing the bromine derivative was dissolved in anhydrous dioxane (1.2 L). Lithium hydride (2.3 g; 0.28 mol) was added in batches and stirred under argon protection at room temperature for 1 h. The reaction was then heated to 110 °C overnight. Upon completion of the reaction, the reaction was quenched with wet dioxane and then quenched with ice water. The reaction solution was concentrated to half of the original volume, the pH was adjusted to 8 with 5 M hydrochloric acid and then evaporated to dryness. After addition of water, the residue was extracted with chloroform and the organic phase was dried over sodium sulfate and concentrated to give a white solid (12.4 g, ~77% yield, containing ~15% bromine derivative). Mass spectrometric analysis (positive ion electrospray) showed m/z 173/5 (Cl MH+) and 217/9 (Br MH+).

References

[1] Patent: US2008/221110, 2008, A1. Location in patent: Page/Page column 18
[2] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 10, p. 2464 - 2469
[3] Patent: WO2008/128953, 2008, A1. Location in patent: Page/Page column 32-33
[4] Patent: WO2008/128961, 2008, A1. Location in patent: Page/Page column 54-55
[5] Patent: WO2008/128942, 2008, A1. Location in patent: Page/Page column 124

3-CHLORO-6,7-DIHYDRO[1,4]DIOXINO[2,3-C]PYRIDAZINESupplier

RuiErKang Pharmaceuticals, Inc.
Tel
2921645477
Email
2921645477@qq.com
BePharm Ltd
Tel
400-685-9117
Email
market@bepharm.com
ChengDu TongChuangYuan Pharmaceutical Co.Ltd
Tel
028-83379370 13880556291
Email
tcy@tcypharm.com
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com
Hangzhou Molcore Biopharmatech Co.,Ltd
Tel
400-711-5280 86-571-81025280
Email
sales@molcore.com
More
Less